Abstract:The expanding gene‐editing toolbox has driven a biomedical revolution. These molecular tools tremendously contribute to the progression of fundamental research, such as epigenetics, drug development, disease modeling, and disease diagnosis. Furthermore, therapeutic gene editing offers a profound opportunity to improve the current treatment of human diseases. The expanding genome editing toolbox has revolutionized life science research ranging from the bench to the bedside. These "molecular scissors" have offered us unprecedented abilities to manipulate nucleic acid sequences precisely in living cells from diverse species. Continued advances in genome editing exponentially broaden our knowledge of human genetics, epigenetics, molecular biology, and pathology. Currently, gene editing‐mediated therapies have led to impressive responses in patients with hematological diseases, including sickle cell disease and thalassemia. With the discovery of more efficient, precise and sophisticated gene‐editing tools, more therapeutic gene‐editing approaches will enter the clinic to treat various diseases, such as acquired immunodeficiency sydrome (AIDS), hematologic malignancies, and even severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These initial successes have spurred the further innovation and development of gene‐editing technology. In this review, we will introduce the architecture and mechanism of the current gene‐editing tools, including clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐associated nuclease‐based tools and other protein‐based DNA targeting systems, and we summarize the meaningful applications of diverse technologies in preclinical studies, focusing on the establishment of disease models and diagnostic techniques. Finally, we provide a comprehensive overview of clinical information using gene‐editing therapeutics for treating various human diseases and emphasize the opportunities and challenges.

Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development

An overview: CRISPR/Cas-based gene editing for viral vaccine development

CRISPR/Cas System Toward the Development of Next-Generation Recombinant Vaccines: Current Scenario and Future Prospects

Development and application of CRISPR/Cas9 technologies in genomic editing.

Research Progress in The Application of CRISPR Gene Editing Technology in Virus Detection and Treatment

Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications

The State-of-the-Art of Gene Editing and its Application to Viral Infections and Diseases Including COVID-19

CRISPR/Cas Technology: The Unique Synthetic Biology Genome-Editing Tool Shifting the Paradigm in Viral Diagnostics, Defense, and Therapeutics

In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease

Recent advances of the biological and biomedical applications of CRISPR/Cas systems

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing

The application of CRISPR/Cas9 technology in infectious diseases

Recent Progress in CRISPR/Cas9 Technology

Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.

Engineering CRISPR/Cas13 System Against RNA Viruses: from Diagnostics to Therapeutics

CRISPR-Cas9 Gene Editing: Current Progress and Future Applications

CRISPR/Cas technology as a promising weapon to combat viral infections

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

CRISPR-Cas9 gene editing technology in human gene therapy: the new realm of medicine

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges